The Quality of Pharmacologic Care for Adults in the United States
- 1 October 2006
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Medical Care
- Vol. 44 (10), 936-945
- https://doi.org/10.1097/01.mlr.0000223460.60033.79
Abstract
Despite rising annual expenditures for prescription drugs, little systematic information is available concerning the quality of pharmacologic care for adults in the United States. We evaluated how frequently appropriate pharmacologic care is ordered in a national sample of U.S. residents. The RAND/UCLA Modified Delphi process was used to select quality-of-care indicators for adults across 30 chronic and acute conditions and preventive care. One hundred thirty-three pharmacologic quality-of-care indicators were identified. We interviewed a random sample of adults living in 12 metropolitan areas in the United States by telephone and received consent to obtain copies of their medical records for the most recent 2-year period. We abstracted patient medical records and evaluated 4 domains of the prescribing process that encompassed the entire pharmacologic care experience: appropriate medication prescribing (underuse), avoidance of inappropriate medications (overuse), medication monitoring, and medication education and documentation. A total of 3,457 participants were eligible for at least 1 quality indicator, and 10,739 eligible events were evaluated. We constructed aggregate scores and studied whether patient, insurance, and community factors impact quality. Participants received 61.9% of recommended pharmacologic care overall (95% confidence interval 60.3-63.5%). Performance was lowest in education and documentation (46.2%); medication monitoring (54.7%) and underuse of appropriate medications (62.6%) performance were higher. Performance was best for avoiding inappropriate medications (83.5%). Patient race and health services utilization were associated with modest quality differences, while insurance status was not. Significant deficits in the quality of pharmacologic care were seen for adults in the United States, with large shortfalls associated with underuse of appropriate medications. Strategies to measure and improve pharmacologic care quality ought to be considered, especially as we initiate a prescription drug benefit for seniors.Keywords
This publication has 38 references indexed in Scilit:
- Who Is at Greatest Risk for Receiving Poor-Quality Health Care?New England Journal of Medicine, 2006
- Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysisBMJ, 2006
- The Effect of Incentive-Based Formularies on Prescription-Drug Utilization and SpendingNew England Journal of Medicine, 2003
- The Quality of Health Care Delivered to Adults in the United StatesNew England Journal of Medicine, 2003
- Adverse Drug Events in Ambulatory CareNew England Journal of Medicine, 2003
- The ethical problem of false positives: a prospective evaluation of physician reporting in the medical recordJournal of Medical Ethics, 2002
- Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme InhibitorsNew England Journal of Medicine, 2002
- Self-restriction of medications due to cost in seniors without prescription coverageJournal of General Internal Medicine, 2001
- Race, Ethnicity, and Pain Treatment: Striving to Understand the Causes and Solutions to the Disparities in Pain TreatmentJournal of Law, Medicine & Ethics, 2001
- Frequency, severity and risk factors for adverse drug reactions in adult out-patients: A prospective studyJournal of Chronic Diseases, 1986